261 related articles for article (PubMed ID: 24657195)
1. The alternative splicing side of cancer.
Biamonti G; Catillo M; Pignataro D; Montecucco A; Ghigna C
Semin Cell Dev Biol; 2014 Aug; 32():30-6. PubMed ID: 24657195
[TBL] [Abstract][Full Text] [Related]
2. Connecting the dots: chromatin and alternative splicing in EMT.
Warns JA; Davie JR; Dhasarathy A
Biochem Cell Biol; 2016 Feb; 94(1):12-25. PubMed ID: 26291837
[TBL] [Abstract][Full Text] [Related]
3. Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT).
Biamonti G; Bonomi S; Gallo S; Ghigna C
Cell Mol Life Sci; 2012 Aug; 69(15):2515-26. PubMed ID: 22349259
[TBL] [Abstract][Full Text] [Related]
4. Multiple effects of digoxin on subsets of cancer-associated genes through the alternative splicing pathway.
Lu GY; Liu ST; Huang SM; Chang YL; Lin WS
Biochimie; 2014 Nov; 106():131-9. PubMed ID: 25193633
[TBL] [Abstract][Full Text] [Related]
5. Regulation of splicing and circularisation of RNA in epithelial mesenchymal plasticity.
Neumann DP; Goodall GJ; Gregory PA
Semin Cell Dev Biol; 2018 Mar; 75():50-60. PubMed ID: 28789987
[TBL] [Abstract][Full Text] [Related]
6. Regulation of alternative splicing through coupling with transcription and chromatin structure.
Naftelberg S; Schor IE; Ast G; Kornblihtt AR
Annu Rev Biochem; 2015; 84():165-98. PubMed ID: 26034889
[TBL] [Abstract][Full Text] [Related]
7. Emerging Multi-cancer Regulatory Role of ESRP1: Orchestration of Alternative Splicing to Control EMT.
Vadlamudi Y; Dey DK; Kang SC
Curr Cancer Drug Targets; 2020; 20(9):654-665. PubMed ID: 32564755
[TBL] [Abstract][Full Text] [Related]
8. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.
Gonçalves V; Matos P; Jordan P
Hum Mol Genet; 2009 Oct; 18(19):3696-707. PubMed ID: 19602482
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
[TBL] [Abstract][Full Text] [Related]
10. A saga of cancer epigenetics: linking epigenetics to alternative splicing.
Narayanan SP; Singh S; Shukla S
Biochem J; 2017 Mar; 474(6):885-896. PubMed ID: 28270561
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Alternative Splicing during Epithelial-Mesenchymal Transition.
Lyu J; Cheng C
Cells Tissues Organs; 2022; 211(2):238-251. PubMed ID: 34348273
[TBL] [Abstract][Full Text] [Related]
12. A splicing twist on metastasis.
Olson OC; Joyce JA
Sci Transl Med; 2013 Jan; 5(169):169fs2. PubMed ID: 23345607
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing in EMT and TGF-β signaling during cancer progression.
Zhang YE; Stuelten CH
Semin Cancer Biol; 2024 Jun; 101():1-11. PubMed ID: 38614376
[TBL] [Abstract][Full Text] [Related]
14. Pre-mRNA splicing: role of epigenetics and implications in disease.
Khan DH; Jahan S; Davie JR
Adv Biol Regul; 2012 Sep; 52(3):377-88. PubMed ID: 22884031
[TBL] [Abstract][Full Text] [Related]
15. Hallmarks of alternative splicing in cancer.
Oltean S; Bates DO
Oncogene; 2014 Nov; 33(46):5311-8. PubMed ID: 24336324
[TBL] [Abstract][Full Text] [Related]
16. Roles and Regulation of Epithelial Splicing Regulatory Proteins 1 and 2 in Epithelial-Mesenchymal Transition.
Göttgens EL; Span PN; Zegers MM
Int Rev Cell Mol Biol; 2016; 327():163-194. PubMed ID: 27692175
[TBL] [Abstract][Full Text] [Related]
17. Determination of a Comprehensive Alternative Splicing Regulatory Network and Combinatorial Regulation by Key Factors during the Epithelial-to-Mesenchymal Transition.
Yang Y; Park JW; Bebee TW; Warzecha CC; Guo Y; Shang X; Xing Y; Carstens RP
Mol Cell Biol; 2016 Jun; 36(11):1704-19. PubMed ID: 27044866
[TBL] [Abstract][Full Text] [Related]
18. EMT and stemness: flexible processes tuned by alternative splicing in development and cancer progression.
Pradella D; Naro C; Sette C; Ghigna C
Mol Cancer; 2017 Jan; 16(1):8. PubMed ID: 28137272
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
[TBL] [Abstract][Full Text] [Related]
20. The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer.
Amirkhah R; Naderi-Meshkin H; Shah JS; Dunne PD; Schmitz U
Cells; 2019 Aug; 8(8):. PubMed ID: 31430887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
